arrow
G

Gary A. Rosenberg

mind research network
H指数:78
被引数:2.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting of phosphorylated tau at threonine 181 by a Qβ virus-like particle vaccine is safe, highly immunogenic, and reduces disease severity in mice and rhesus macaques

Qβ病毒样颗粒疫苗靶向181位苏氨酸磷酸化tau蛋白,是安全的、具有高度免疫原性的,并且能够减轻小鼠和恒河猴的疾病严重程度。

2025-03-270
OAAI
White matter free water mediates the associations between placental growth factor, white matter hyperintensities, and cognitive status

白质游离水介导胎盘生长因子,白质高信号和认知状态之间的关联

2024-12-180
OA
Biological validation of peak-width of skeletonized mean diffusivity as a VCID biomarker: The MarkVCID Consortium

骨架化平均扩散率峰宽作为VCID生物标志物的生物学验证: MarkVCID联盟

2024-11-210
OAAI
Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol

MarkVCID白质高强度生长和回归协议的多站点跨站点间评分者和重测信度和结构效度

2023-11-070
OA
Placental growth factor as a sensitive biomarker for vascular cognitive impairment
2023-02-2322
PRE
MRI free water as a biomarker for cognitive performance: Validation in the MarkVCID consortium
2022-12-135
OAAI
Instrumental validation of free water, peak-width of skeletonized mean diffusivity, and white matter hyperintensities: MarkVCID neuroimaging kits

自由水,骨架平均扩散率的峰宽和白质高信号的仪器验证: MarkVCID神经成像试剂盒

2022-03-2844
OA
Expanding the horizon of research into the pathogenesis of the white matter diseases: Proceedings of the 2021 Annual Workshop of the Albert Research Institute for White Matter and Cognition

扩大白质疾病发病机制的研究范围: 艾伯特白质与认知研究所2021年度研讨会论文集

2021-10-045
OAAI
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols

MarkVCID脑小血管联盟: I.登记,临床,流体方案

2021-01-2147
OAAI